Genetics Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A future study linking tumor genetics with CLL dynamics
New genetic sequencing techniques could yield profound insights into disease progression in chronic lymphocytic leukemia (CLL). Niamph Appleby, MB, BAO, BCh, MRCPI, FRCPath, from the the Royal Marsden... Author: VJHemOnc Added: 07/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 20, 2018 Category: Cancer & Oncology Source Type: podcasts

Developing a patient-reported outcome instrument for Gaucher disease
There are several genetic instruments available to measure the impact of Gaucher Disease (GD) on a patients quality of life, but no specific measure by which patients can report this information them... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Combining MRD with genetic knowledge in ALL
Measurable residual disease (MRD) is arguably the most useful single prognostic tool we have within the field of acute lymphoblastic leukemia (ALL), discusses Anthony Moorman, PhD, of Newcastle Univer... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Genetic screening to inform CLL treatment
Biomarker screening has become an essential component of constructing treatment plans in chronic lymphocytic leukemia (CLL). In this video, recorded at the 23rd Congress of the European Hematology Ass... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

UKALL14: implementing genetics in ALL research
Anthony Moorman, PhD, of Newcastle University, Newcastle, UK, discusses the current UKALL14 trial (NCT01085617) for adults aged 25-65 with acute lymphoblastic leukemia (ALL). The trial is the first of... Author: VJHemOnc Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts

Linking Gaucher disease with Parkinsons disease
Gaucher disease (GD) is a rare genetic disorder which is seldom diagnosed because of its rarity, although diagnoses can be achieved easily with enzyme or bone marrow testing, as well as genetic tests.... Author: VJHemOnc Added: 07/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Integrating genetic screening into treatment planning for high risk MM
Treatment of multiple myeloma (MM) has improved greatly over the past few years; however, certain patients remain at high risk of rapid relapse, either because of general background traits, or because... Author: VJHemOnc Added: 07/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2018 Category: Cancer & Oncology Source Type: podcasts

Optimal Target HbA1c, Genetic Risks for Pancreatic Cancer, US Trends in Obesity, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 19, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - June 19, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

09 John Ioannidis
Series two of The Recommended Dose kicks off with polymath and poet, Dr John Ioannidis. Recognised by The Atlantic as one the most influential scientists alive today, he ’s a global authority on genetics, medical research and the nature of scientific inquiry itself – among many other things. A professor at Stanford University, John has authored close to 1,000 academic papers and served on the editorial boards of 30 of the world's top journals. He is best known for seriously challenging the status quo. His trailblazing 2005 paper 'Why Most Published Research Findings Are False' has been viewed over 2.5 million times an...
Source: The BMJ Podcast - June 15, 2018 Category: General Medicine Authors: The Recommended Dose with Ray Moynihan Source Type: podcasts

09 John Ioannidis
Series two of The Recommended Dose kicks off with polymath and poet, Dr John Ioannidis. Recognised by The Atlantic as one the most influential scientists alive today, he’s a global authority on genetics, medical research and the nature of scientific inquiry itself – among many other things. A professor at Stanford University, John has authored close to 1,000 academic papers and served on the editorial boards of 30 of the world's top journals. He is best known for seriously challenging the status quo. His trailblazing 2005 paper 'Why Most Published Research Findings Are False' has been viewed over 2.5 million times and...
Source: The BMJ Podcast - June 15, 2018 Category: General Medicine Authors: BMJ Group Source Type: podcasts

The current treatment landscape for penile cancer
With the involvement of so many genetic and molecular alterations in cancer, it is nearly impossible to know what pathway to target for a clinically significant outcome that also has a low toxicity le... Author: VJOncology Added: 06/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 8, 2018 Category: Cancer & Oncology Source Type: podcasts

Increasing AML clinical trial participation rates
Despite major advancements in the understanding of the genetic drivers of acute myeloid leukemia (AML) and the pathophysiology of the disease, standard treatment options for AML patients have not expe... Author: VJHemOnc Added: 05/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 29, 2018 Category: Cancer & Oncology Source Type: podcasts